Alex STUDIER
Alle deler > ALEXANDRA
Finsen AV.
MOLECULAR MECHANISMS IN HEART FAILURE. THE ROLE OF SYNDECAN-4 IN DEVELOPMENT OF MYOCARDIAL HYPERTROPHY AND HEART FAILUREThesis 2008, Faculty of Medicine, Oslo University
Dhondup Y, Sjaastad I, Sandanger Ø, Aronsen JM, Ahmed MS, Attramadal H, Finsen AV, Zhang L, Ranheim T, Alfsnes K, Aukrust P, Christensen G, Yndestad A, Vinge LE.
Mediators Inflamm 2017; 9450439. doi: 10.1155/2017/9450439
Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators.
THE CHANGING LANDSCAPE FOR STROKE PREVENTION IN AF: FINDINGS FROM THE GLORIA-AF REGISTRY PHASE 2.J Am Coll Cardiol. 2017; 69:777-85. doi: 10.1016/j.jacc.2016.11.061
Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P, Yndestad A, Aukrust P, Bjørås M, Finsen AV.
NEIL3-DEPENDENT REGULATION OF CARDIAC FIBROBLAST PROLIFERATION PREVENTS MYOCARDIAL RUPTURE.Cell Rep 2017;18:82-92. doi: 10.1016/j.celrep.2016.12.009
Sokolova M, Vinge LE, Alfsnes K, Olsen MB, Eide L, Kaasbøll OJ, Attramadal H, Torp MK, Fosshaug LE, Rashidi A, Lien E, Finsen AV, Sandanger Ø, Aukrust P, Ranheim T, Yndestad A.
PALMITATE PROMOTES INFLAMMATORY RESPONSES AND CELLULAR SENESCENCE IN CARDIAC FIBROBLASTS.Biochim Biophys Acta Mol Cell Biol Lipids 2017; 1862:234-245. doi: 10.1016/j.bbalip.2016.11.003
Dhondup Y, Ueland T, Dahl CP, Askevold ET, Sandanger Ø, Fiane A, Ohm IK, Sjaastad I, Finsen AV, Wæhre A, Gullestad L, Aukrust P, Yndestad A, Vinge LE.
LOW CIRCULATING LEVELS OF MITOCHONDRIAL AND HIGH LEVELS OF NUCLEAR DNA PREDICT MORTALITY IN CHRONIC HEART FAILURE.J Card Fail 2016;22:823-8. doi: 10.1016/j.cardfail.2016.06.013
Finsen AV, Ueland T, Sjaastad I, Ranheim T, Ahmed MS, Dahl CP, Askevold ET, Aakhus S, Husberg C, Fiane AE, Lipp M, Gullestad L, Christensen G, Aukrust P, Yndestad A.
THE HOMEOSTATIC CHEMOKINE CCL21 PREDICTS MORTALITY IN AORTIC STENOSIS PATIENTS AND MODULATES LEFT VENTRICULAR REMODELING.PLoS One 2014; 9: e112172. doi: 10.1371/journal.pone.0112172
Ohm IK, Alfsnes K, Belland Olsen M, Ranheim T, Sandanger Ø, Dahl TB, Aukrust P, Finsen AV, Yndestad A, Vinge LE.
TOLL-LIKE RECEPTOR 9 MEDIATED RESPONSES IN CARDIAC FIBROBLASTS.PLoS One 2014; 9: e104398. doi: 10.1371/journal.pone.0104398.
Sandanger Ø, Ranheim T, Vinge LE, Bliksøen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A.
THE NLRP3 INFLAMMASOME IS UP-REGULATED IN CARDIAC FIBROBLASTS AND MEDIATES MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY.Cardiovasc Res 2013; 99: 164-74. doi: 10.1093/cvr/cvt091
Gullestad L, Ueland T, Vinge LE, Finsen A, Yndestad A, Aukrust P.
INFLAMMATORY CYTOKINES IN HEART FAILURE: MEDIATORS AND MARKERS.Cardiology 2012;122:23-35. doi: 10.1159/000338166
Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P.
THE HOMEOSTATIC CHEMOKINE CCL21 PREDICTS MORTALITY AND MAY PLAY A PATHOGENIC ROLE IN HEART FAILURE.PLoS One 2012; 7: e33038. doi: 10.1371/journal.pone.0033038
Finsen AV, Lunde IG, Sjaastad I, Østli EK, Lyngra M, Jarstadmarken HO, Hasic A, Nygård S, Wilcox-Adelman SA, Goetinck PF, Lyberg T, Skrbic B, Florholmen G, Tønnessen T, Louch WE, Djurovic S, Carlson CR, Christensen G.
SYNDECAN-4 IS ESSENTIAL FOR DEVELOPMENT OF CONCENTRIC MYOCARDIAL HYPERTROPHY VIA STRETCH-INDUCED ACTIVATION OF THE CALCINEURIN-NFAT PATHWAY.PLoS One 2011; 6: e28302. doi: 10.1371/journal.pone.0028302
Waehre A, Halvorsen B, Yndestad A, Husberg C, Sjaastad I, Nygård S, Dahl CP, Ahmed MS, Finsen AV, Reims H, Louch WE, Hilfiker-Kleiner D, Vinge LE, Roald B, Attramadal H, Lipp M, Gullestad L, Aukrust P, Christensen G.
LACK OF CHEMOKINE SIGNALING THROUGH CXCR5 CAUSES INCREASED MORTALITY, VENTRICULAR DILATATION AND DERANGED MATRIX DURING CARDIAC PRESSURE OVERLOAD.PLoS One 2011; 6: e18668. doi: 10.1371/journal.pone.0018668
Bjørnstad JL, Sjaastad I, Nygård S, Hasic A, Ahmed MS, Attramadal H, Finsen AV, Christensen G, Tønnessen T.
COLLAGEN ISOFORM SHIFT DURING THE EARLY PHASE OF REVERSE LEFT VENTRICULAR REMODELLING AFTER RELIEF OF PRESSURE OVERLOAD.Eur Heart J 2011; 32: 236-45. doi: 10.1093/eurheartj/ehq166
Røsjø H, Husberg C, Dahl MB, Stridsberg M, Sjaastad I, Finsen AV, Carlson CR, Oie E, Omland T, Christensen G.
CHROMOGRANIN B IN HEART FAILURE: A PUTATIVE CARDIAC BIOMARKER EXPRESSED IN THE FAILING MYOCARDIUM.Circ Heart Fail 2010; 3: 503-11. doi: 10.1161/CIRCHEARTFAILURE.109.867747
Iversen PO, Andersson KB, Finsen AV, Sjaastad I, von Lueder TG, Sejersted OM, Attramadal H, Christensen G.
SEPARATE MECHANISMS CAUSE ANEMIA IN ISCHEMIC VS. NONISCHEMIC MURINE HEART FAILURE.Am J Physiol Regul Integr Comp Physiol 2010; 298: R808-14. doi: 10.1152/ajpregu.00250.2009
Dahl CP, Husberg C, Gullestad L, Waehre A, Damås JK, Vinge LE, Finsen AV, Ueland T, Florholmen G, Aakhus S, Halvorsen B, Aukrust P, Oie E, Yndestad A, Christensen G.
INCREASED PRODUCTION OF CXCL16 IN EXPERIMENTAL AND CLINICAL HEART FAILURE: A POSSIBLE ROLE IN EXTRACELLULAR MATRIX REMODELING.Circ Heart Fail 2009; 2: 624-32. doi: 10.1161/CIRCHEARTFAILURE.108.821074
Andersson KB, Finsen AV, Sjåland C, Winer LH, Sjaastad I, Odegaard A, Louch WE, Wang Y, Chen J, Chien KR, Sejersted OM, Christensen G.
MICE CARRYING A CONDITIONAL SERCA2(FLOX) ALLELE FOR THE GENERATION OF CA(2+) HANDLING-DEFICIENT MOUSE MODELS.Cell Calcium 2009; 46: 219-25. doi: 10.1016/j.ceca.2009.07.004
Andersson KB, Birkeland JA, Finsen AV, Louch WE, Sjaastad I, Wang Y, Chen J, Molkentin JD, Chien KR, Sejersted OM, Christensen G.
MODERATE HEART DYSFUNCTION IN MICE WITH INDUCIBLE CARDIOMYOCYTE-SPECIFIC EXCISION OF THE SERCA2 GENE.J Mol Cell Cardiol 2009; 47: 180-7. doi: 10.1016/j.yjmcc.2009.03.013
Husberg C, Nygård S, Finsen AV, Damås JK, Frigessi A, Oie E, Waehre A, Gullestad L, Aukrust P, Yndestad A, Christensen G.
CYTOKINE EXPRESSION PROFILING OF THE MYOCARDIUM REVEALS A ROLE FOR CX3CL1 (FRACTALKINE) IN HEART FAILURE.J Mol Cell Cardiol 2008; 45: 261-9. doi: 10.1016/j.yjmcc.2008.05.009
Finsen AV, Christensen G, Sjaastad I.
ECHOCARDIOGRAPHIC PARAMETERS DISCRIMINATING MYOCARDIAL INFARCTION WITH PULMONARY CONGESTION FROM MYOCARDIAL INFARCTION WITHOUT CONGESTION IN THE MOUSE.J Appl Physiol (1985) 2005; 98: 680-9.
Knudsen CW, Riis JS, Finsen AV, Eikvar L, Müller C, Westheim A, Omland T.
DIAGNOSTIC VALUE OF A RAPID TEST FOR B-TYPE NATRIURETIC PEPTIDE IN PATIENTS PRESENTING WITH ACUTE DYSPNOE: EFFECT OF AGE AND GENDER.Eur J Heart Fail 2004; 6: 55-62.
Finsen AV, Woldbaek PR, Li J, Wu J, Lyberg T, Tønnessen T, Christensen G.
Physiol Genomics 2004; 16: 301-8.